Physician profile
Michael Li
NPI 1720481534
$2,154.51
in general payments reported to CMS, 2019-2025
10 companies · $710 in 2025
The $710 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $262 · 2024: $1,183 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.51 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2024 | |
| Abbott Laboratories | $363.45 | 2025 | Aveir, Jot Dx, Amplatzer Amulet |
| Cardiva Medical, INC. | $265.57 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Medtronic, INC. | $263.99 | 2023-2025 | Affera Mapping System, Azure Xt Dr Mri Surescan, Micra |
| Amgen INC. | $114.39 | 2025 | |
| Pfizer INC. | $49.40 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $32.21 | 2023-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $25.22 | 2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $21.82 | 2024 | |
| Glaxosmithkline, LLC. | $18.46 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.